Resources from the same session
LBA7 - Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the KEYNOTE-177 study Asia subgroup
Presenter: Takayuki Yoshino
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
90MO - Panitumumab (PAN) vs bevacizumab (BEV) in metastatic colorectal cancer (mCRC) by microsatellite stable (MSS), RAS/BRAF, and HER2 amplification (HER2amp) status: Phase III PARADIGM biomarker study
Presenter: Takeshi Kato
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Webcast
91MO - Sotorasib plus panitumumab versus standard-of-care for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC): CodeBreak 300 phase III study
Presenter: Yasutoshi Kuboki
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
92MO - Sotorasib (Soto) + panitumumab (Pmab) and FOLFIRI in previously treated KRASG12C-mutated metastatic colorectal cancer (mCRC): Safety and efficacy for CodeBreaK 101 phase Ib expansion cohort
Presenter: Toshiki Masuishi
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Webcast
132MO - Zanidatamab (ZW25; Zani) in patients (pts) with previously treated advanced human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC): Asia subgroup analysis of the phase IIb HERIZON-BTC-01 study
Presenter: Huichuan Sun
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
133MO - Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966
Presenter: Richard Finn
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 132MO and 133MO
Presenter: Angela Lamarca
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Webcast